I could be wrong but we are being assessed against the current standard of care. That is currently other TAVR devices. So I assume we would publish our results against the thousands of existing published results for existing on market devices. (these well documented results make up the current standard of care.)
I don’t think we actually implant other companies devices in this trial.
Not advice and DYOR.
I could be wrong but we are being assessed against the current...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.50 |
Change
0.100(0.65%) |
Mkt cap ! $327.6M | |||
| Open | High | Low | Value | Volume |
| $15.15 | $15.50 | $15.00 | $108.6K | 7.185K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 341 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 371 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |